Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Light fixture
Methods, systems, and products for providing ring backs
System and method for providing security in browser-based access to smart cards
Touchscreen with extended conductive pattern
Data communication system, data transmitting apparatus, data transmitting method, and method for determining packet size and redundancy
Isothermal amplification of DNA
Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
  Randomly Featured Patents
Screen printing form and flexible screen printing form accommodating device
Method of controlling cellular processes in plants
High speed charge pump
Ink-jet compatible latexes
Method and apparatus for catching fleas
Sulfurized olefin adducts of dihydrocarbyl phosphites and lubricant compositions containing same
Internal combustion engine
Magnetic head
Double beam spectrometer
Retarder and optical head device installing the same